Colinz Laboratories Limited — Quarter and year ended 31st March, 2026
| S. No. | Particulars | Audited Quarter ended | Un-Audited Quarter ended | Audited Year Ended |
|---|---|---|---|---|
| 31-Mar-26 | 31-Mar-25 | 31-Dec-25 | ||
| PART – I | ||||
| 1 | (a) Revenue from Operation | 174.79 | 145.14 | 143.41 |
| 3 | (b) Other Income | 17.45 | 7.56 | 7.54 |
| 3 | Total Income from Operation | 192.24 | 152.70 | 150.95 |
| 4 | Expenses | |||
| (a) Cost Of Material Consumed | 11.37 | 9.58 | 10.69 | |
| (b) Purchase of Stock in Trade | 25.73 | 26.91 | 26.18 | |
| (c) Change in Inventories Of Finished Goods and Work in Progress and Stock in Trade | 21.14 | 14.09 | 10.32 | |
| (d) Employee Benefit Expenses | 69.50 | 69.72 | 58.42 | |
| (e) Finance Cost | 1.05 | 1.61 | 1.13 | |
| (f) Depreciation & Amortisation Expenses | 3.91 | 3.46 | 3.91 | |
| (g) Other Expenses | 37.96 | 15.01 | 27.69 | |
| Total Expenses | 170.66 | 140.38 | 138.34 | |
| 5 | Profit / (Loss) Before exceptional items and tax (3-4) | 21.58 | 12.32 | 12.61 |
| 6 | Exceptional items | – | – | – |
| 7 | Profit / (Loss) before tax (5-6) | 21.58 | 12.32 | 12.61 |
| 8 | Tax Expenses (Provision for Taxation) Current tax | |||
| i) Current Tax | 6.00 | 2.50 | 4.25 | |
| ii) Deferred Tax | (1.54) | (5.22) | – | |
| iii) Tax for earlier years | – | – | – | |
| iv) MAT Credit of Earlier years | – | – | – | |
| 9 | Profit /(Loss) for the period from continuing operations (7-8) | 17.12 | 15.04 | 8.36 |
| 10 | Profit /(Loss) for the period | 17.12 | 15.04 | 8.36 |
| 11 | Other Comprehensive Income (Net of Tax) | |||
| A) Item that will not be reclassified to Profit or Loss Account | ||||
| i) Change in fair value of investment in Equity Instruments | (16.79) | 4.53 | 7.93 | |
| 12 | Total Comprehensive Income for the period (10+11) Comprising | 0.33 | 19.57 | 16.29 |
| 13 | Earning per equity share (for Continuing operation) (In Rs.) | |||
| i) Basic | 0.68 | 0.60 | 0.33 | |
| ii) Diluted | 0.68 | 0.60 | 0.33 |
| Particulars | 31-Mar-2026 | 31-Mar-2025 |
|---|---|---|
| Non-Current Assets | ||
| a) Property, Plants & Equipment | 154.43 | 170.05 |
| b) Capital Work-in progress | – | – |
| c) Intangible Assets | – | – |
| d) Financial Assets | ||
| i) Investments | 110.63 | 104.44 |
| ii) Loans | – | – |
| iii) Other Financial Assets | – | – |
| e) Other Non Current Assets | 5.41 | 5.60 |
| Total Non-Current Assets | 270.47 | 280.09 |
| Current Assets | ||
| a) Inventories | 70.35 | 78.09 |
| b) Financial Assets | ||
| i) Trade Receivables | 83.51 | 66.09 |
| ii) Cash & Cash Equivalents | 70.34 | 240.03 |
| iii) Other Bank Balances | 782.57 | 314.99 |
| iv) Other Financial Assets | – | – |
| c) Other Current Assets | 0.91 | 202.45 |
| Total Current Assets | 1007.68 | 901.65 |
| TOTAL ASSETS | 1278.15 | 1181.74 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| a) Equity Share Capital | 251.91 | 251.91 |
| b) Other Equity | 752.40 | 695.53 |
| Total Equity | 1004.31 | 947.44 |
| Liabilities | ||
| Non-Current Liabilities | ||
| a) Deferred Tax Liabilities (Net) | 17.29 | 18.06 |
| b) Other Non Current Liabilities | – | – |
| Total Non-Current Liabilities | 17.29 | 18.06 |
| Current Liabilities | ||
| a) Financial Liabilities | ||
| i) Borrowings | 38.99 | 64.09 |
| ii) Trade Payables | 38.26 | 54.31 |
| b) Other Current Liabilities | 166.08 | 85.65 |
| c) Current Provisions | 13.22 | 12.19 |
| Total Current Liabilities | 256.55 | 216.24 |
| TOTAL EQUITY AND LIABILITIES | 1278.15 | 1181.74 |
| Particulars | April 01, 2025 To March 31, 2026 | April 01, 2024 To March 31, 2025 |
|---|---|---|
| A) CASH FLOW FROM OPERATING ACTIVITIES: | ||
| Profit Before Taxation | 68.91 | 61.94 |
| Adjustments for: | ||
| Depreciation/Impairment | 15.63 | 13.12 |
| Loss on sale of Assets | 0.00 | 0.00 |
| Interest Expense | 4.66 | 4.24 |
| Interest Income | (47.32) | (28.04) |
| Dividend Income | (1.13) | (0.84) |
| Operating Profit Before Working Capital Changes | 40.75 | 50.42 |
| Adjustments for changes in working capital: | ||
| Increase / (Decrease) in Trade Payable | (16.05) | (5.45) |
| Increase / (Decrease) in Short Term Borrowings | (25.10) | 7.11 |
| Increase / (Decrease) in Current Provisions | 1.03 | 3.12 |
| Increase / (Decrease) in Other Current Liabilities | 80.43 | (6.69) |
| Increase / (Decrease) in Other Long Term Current Liabilities | 0.00 | 0.00 |
| (Increase) / Decrease in Trade Receivables | (17.42) | 19.83 |
| (Increase) / Decrease in Inventories | 7.74 | 6.60 |
| (Increase) / Decrease in Other Non Current Assets | 0.19 | 0.00 |
| (Increase) / Decrease in Other Current Assets | 201.54 | (199.55) |
| Cash Generated /(Used In) from Operations | 273.11 | (124.61) |
| Taxes Paid (Net) | (19.00) | (20.76) |
| Net Cash generated from /(Used In) Operating Activities | 254.11 | (145.37) |
| B) CASH FLOW FROM INVESTING ACTIVITIES: | ||
| Purchase of Fixed Assets | 0.00 | (26.19) |
| Sales of Mutual Funds | 0.00 | 1.92 |
| Dividend Income | 1.13 | 0.84 |
| Net Cash (Used In) Investing Activities | 1.13 | (23.43) |
| C) CASH FLOW FROM FINANCING ACTIVITIES: | ||
| Interest received | 47.32 | 28.04 |
| Interest Expense | (4.66) | (4.24) |
| Net Cash (Used In) /generated from Financing Activities | 42.66 | 23.80 |
| Net increase in Cash and Cash Equivalents (A+B+C) | 297.90 | (145.00) |
| Cash and Cash Equivalents as at the beginning of the year | 555.01 | 700.01 |
| Cash and Cash Equivalents as at the end of the year | 852.91 | 555.01 |
| Net increase / (decrease) in cash and cash equivalents | 297.90 | (145.00) |
| Cash and Cash Equivalents comprise of: | ||
| Cash in Hand | 0.28 | 0.53 |
| Balances with Scheduled Banks in: | ||
| – Current Accounts | 70.06 | 239.49 |
| Other Bank Balances | 782.57 | 314.99 |
| 852.91 | 555.01 |